This will be filed as a serious injury summary report per fda exemption approval number - e2015009.The device was not returned for analysis.A review of the lot history record could not be performed due to unknown lot information.Based on the limited information reviewed, a cause for the reported atrial perforation events could not be determined.The reported patient effect of atrial perforation, as listed in the mitraclip instructions for use (ifu), is a known possible complication associated with mitraclip procedures.There is no indication of a product issue with respect to manufacture, design, or labeling.
|
It was reported through transcatheter valve therapy (tvt) registry data that mitraclip devices may be related to 32 atrial septal defect requiring intervention events which is considered a serious injury.The relationship of the adverse events to the mitraclip device could not be determined based on the limited data received from the registry.Patients¿ mean age 73 years, ranging from 30 - 90 years.72% patients were male, 28% patients were female.Tvt registry data is reported as a summary per summary reporting exemption approval number - e2015009.No additional information was provided.
|